Home › Funds › Atle Fund Management AB › PYXS
Atle Fund Management AB position in PYXS
PYXIS ONCOLOGY INC · Health Care
Atle Fund Management AB reported holding 663,772 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 0.41% of its reported portfolio and ranking #38 among its reported holdings. Atle Fund Management AB has disclosed PYXS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Atle Fund Management AB's PYXS position evolved
Atle Fund Management AB first disclosed a stake in PYXS in Q4 2025 at 617,245 shares (US$710K). The position peaked in Q2 2026 at 966,459 shares, worth US$2.9M. Across 4 filings, Atle Fund Management AB increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 663,772 shares valued at US$1.5M — a reduction of -302,687 shares quarter over quarter.. Notable position changes include a 68% trim in Q1 2026 (shares rose 106% over the following quarter), a 390% increase in Q2 2026 (shares fell 23% over the following quarter), a 31% trim in Q3 2026 (shares fell 30% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 617.25K | $709.83K | New |
| Q1 2026 | 197.04K | $1.62M | Reduce |
| Q2 2026 | 966.46K | $2.91M | Add |
| Q3 2026 | 663.77K | $1.55M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PYXS and 13F data
PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 29 other funds we track also report a position in PYXS — the largest reported positions include GordonMD Global Investments LP (US$30.2M), PFIZER INC (US$20.1M), Laurion Capital Management LP (US$14.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PYXS
- GordonMD Global Investments LP 10.02M sh · $30.17M · Q2 2026
- PFIZER INC 7.03M sh · $20.11M · Q3 2026
- Laurion Capital Management LP 4.90M sh · $14.75M · Q2 2026
- Palo Alto Investors LP 864.28K sh · $2.60M · Q2 2026
- Decheng Capital LLC 326.81K sh · $983.70K · Q2 2026
More on Atle Fund Management AB
FAQ
How long has Atle Fund Management AB held PYXS?
Atle Fund Management AB has disclosed PYXS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Atle Fund Management AB's current position in PYXS?
As of Q3 2026, Atle Fund Management AB holds 663.77K shares of PYXS (PYXIS ONCOLOGY INC), valued at $1.55M, representing 0.41% of its reported portfolio and ranking #38.
Has Atle Fund Management AB been buying or selling PYXS?
In the latest 13F filing (Q3 2026), Atle Fund Management AB reduced its position in PYXS. The position peaked in Q2 2026 at 966.46K shares.
Which other funds hold PYXS?
Other major institutional holders of PYXS include GordonMD Global Investments LP, PFIZER INC, Laurion Capital Management LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.